Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$32.85 - $40.26 $574,875 - $704,550
-17,500 Reduced 51.17%
16,700 $634,000
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $246,524 - $326,625
7,500 Added 28.09%
34,200 $1.14 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $1.45 Million - $1.68 Million
-38,300 Reduced 58.92%
26,700 $1.14 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $355,152 - $436,240
11,200 Added 20.82%
65,000 $2.51 Million
Q3 2023

Nov 15, 2023

BUY
$37.32 - $49.29 $2.01 Million - $2.65 Million
53,800 New
53,800 $2.03 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.